SYNthesis Med Chem

SYNthesis Med Chem is a startup based in Australia. SYNthesis Med Chem has been acquired. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

SYNthesis Med Chem provides small molecule drug discovery services including medicinal chemistry, synthetic chemistry, integrated drug discovery, and custom compound synthesis to support progression from hit discovery to clinical candidates.